The biologics market has emerged as one of the fastest-growing segments within the global pharmaceutical industry, driven by advancements in biotechnology, rising prevalence of chronic diseases, and increasing demand for targeted therapies. Biologics, derived from living organisms, include a wide range of products such as monoclonal antibodies, vaccines, recombinant proteins, and gene...
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek